Statins and coronary heart disease

Lancet

Volumn 347, Issue 9012, 1996, Pages 1389-1390

  Fey, R ^a   Pearson, N ^a  

^a Avon Health Authority   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRAVASTATIN; STATIN;

CHOLESTEROL BLOOD LEVEL; COST BENEFIT ANALYSIS; DRUG COST; DRUG EFFICACY; HUMAN; ISCHEMIC HEART DISEASE; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION; SHORT SURVEY;

EID: 0030009390     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)91019-3     Document Type: Article

References (17)

1. Oliver MF. Statins prevent coronary heart disease. Lancet 1995; 346: 1378-79.
2. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-89.
3. Shepherd J, Cobbe M, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. N Engl J Med 1995; 333: 1301-07.
4. Office for Population Censuses and Surveys. Series PP2, no 19. London: HM Stationery Office, 1995.
5. British National Formulary, September, 1995.
6. The WOSCOPS Study Group. Screening experience and baseline characteristics in the West of Scotland Coronary Prevention Study. Am J Cardiol 1995; 76: 485-91.
7. Health Survey for England 1993, OPCS Social Survey Division. London: HM Stationery Office, 1995.
8. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham Study. JAMA 1987; 257: 2176-80.
9. Krumholz HM, Seeman TE, Merrill SS, et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA 1994; 272: 1335-40.
10. Garber AM, Browner WS, Hulley SB. Cholesterol screening in asymptomatic adults, revisited. Ann Intern Med 1996; 124: 518-31.
11. American College of Physicians. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Ann Intern Med 1996; 124: 515-17.
12. Haq IU, Jackson PR, Yeo WW, Ramsay LE. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet 1995; 346: 1467-71.
13. Andrade SE, Walker AM, Gottleib LK, et al. Discontinuation of antihyperlipidaemic drugs: do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med 1995; 332: 1125-31.
14. Pedersen TR. Lowering cholesterol with drugs and diet. N Engl J Med 1995; 333: 1350-51.
15. Rose GA. Strategy of prevention: lessons from cardiovascular disease. BMJ 1981; 282: 1847-51.
16. Foulds J, Godfrey G. Counting the costs of children's smoking. BMJ 1995; 311: 1152-54.
17. Dean M. British health rationing becomes explicit. Lancet 1995; 346: 1415.